7月16日，哈门那盘中上涨4.85%，报414.58美元/股，成交额6533.99万美元。
消息面上，医疗保健板块在前一交易日集体承压后迎来强势反弹，同板块联合健康大涨8.77%领涨行业。近期多家投行密集上调哈门那目标价：Truist将目标价从320美元上调至415美元，加拿大皇家银行从246美元大幅上调至415美元，均维持持有评级；此前伯恩斯坦已将目标价上调至425美元并维持"跑赢大市"评级。公司一季度调整后EPS为10.31美元超预期，并重申全年至少9美元/股的盈利指引，叠加2027年Medicare Advantage费率最终通知较初步方案显著改善，基本面预期持续向好。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.